Literature DB >> 18467371

Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer.

C G Fraser1, C M Mathew, K McKay, F A Carey, R J C Steele.   

Abstract

BACKGROUND: Simple card collection systems are becoming available for faecal immunochemical tests (FITs) as well as guaiac faecal occult blood tests (gFOBTs). FITs are now obtainable that allow quantitation of haemoglobin, so that the analytical detection limit can be set to give a positivity rate that is manageable in terms of the available colonoscopy. A combination of a card collection device and an automated FIT analytical system could be advantageous.
METHODS: The quantitation of haemoglobin in samples collected on cards with a new analytical system and the relationship between faecal haemoglobin concentration and pathology were investigated in a cohort of gFOBT-positive individuals.
RESULTS: All groups had large ranges of haemoglobin concentration and there was overlap between the groups. Median haemoglobin concentrations in participants with normal findings on colonoscopy (167), diverticular disease (43), hyperplastic polyps (41), low risk adenoma (63), higher risk adenoma (35) and cancer (27) were 13.5, 15.6, 16.8, 15.2, 65.6 and 168.9 ng/ml haemoglobin, respectively. Those with diverticular disease, hyperplastic polyps and low risk adenoma were not significantly different from the normal group (p>0.2), but those with higher risk adenoma had significantly higher concentrations (p<0.001), as did those with cancer (p<0.001). Receiver operating characteristic analysis demonstrates that the cut-off concentration can be set to give appropriate clinical characteristics; optimum sensitivity and specificity are achieved at 26.7 ng/ml.
CONCLUSIONS: The haemoglobin in faeces on simple FIT card collection devices can be immunoturbidimetrically analysed quantitatively, and the concentration relates to the presence or absence of significant neoplastic disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467371     DOI: 10.1136/gut.2008.153494

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  5 in total

1.  Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia.

Authors:  Chao-Sheng Liao; Yu-Min Lin; Hung-Chuen Chang; Yu-Hung Chen; Lee-Won Chong; Chun-Hao Chen; Yueh-Shih Lin; Kuo-Ching Yang; Chia-Hui Shih
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

2.  Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.

Authors:  L Sharp; L Tilson; S Whyte; A O'Ceilleachair; C Walsh; C Usher; P Tappenden; J Chilcott; A Staines; M Barry; H Comber
Journal:  Br J Cancer       Date:  2012-02-16       Impact factor: 7.640

3.  Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death.

Authors:  Li-Sheng Chen; Amy Ming-Fang Yen; Callum G Fraser; Sherry Yueh-Hsia Chiu; Jean Ching-Yuan Fann; Po-En Wang; Sheng-Che Lin; Chao-Sheng Liao; Yi-Chia Lee; Han-Mo Chiu; Hsiu-Hsi Chen
Journal:  BMJ Open       Date:  2013-11-07       Impact factor: 2.692

4.  Tests detecting biomarkers for screening of colorectal cancer: What is on the horizon?

Authors:  Angaja Phalguni; Helen Seaman; Kristina Routh; Stephen Halloran; Sue Simpson
Journal:  GMS Health Technol Assess       Date:  2015-06-10

5.  Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.

Authors:  L Hol; J A Wilschut; M van Ballegooijen; A J van Vuuren; H van der Valk; J C I Y Reijerink; A C M van der Togt; E J Kuipers; J D F Habbema; M E van Leerdam
Journal:  Br J Cancer       Date:  2009-04-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.